BioNtech in bid to increase vaccine production by 750 million doses a year
Covid-19 vaccine co-manufacturer buys new manufacturing plant from Novartis in Germany to ramp up production
BioNtech hopes to increase the production of Covid-19 vaccines by an additional 750 million doses a year in Europe, the company’s chief commercial officer has told the Business Post.
Sean Marrett of BioNtech, who alongside Pfizer have brought the first Covid-19 vaccine to market, said the company had just bought a new manufacturing plant from Novartis in Germany, and it could produce an additional 750 million doses of the vaccine a year, should it...
Subscribe from just €1 for the first month!
With any subscription you will have access to
Unlimited multi-device access to our iPad, iPhone and Android Apps
Unlimited access to our eReader library
Exclusive daily insight and opinion seven days a week
Create alerts to never miss a subject that matters to you
Get access to exclusive offers for subscribers on gifts and experiences
Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine
Enterprise Ireland chief: global supply chain backlog ‘to continue for another year’
Leo Clancy also says sustainability has risen high on the agenda of Irish companies in his first year in the role of chief executive
Premier Inn owner files €1.75m loss due to pandemic
Pi Hotels & Restaurants Ireland is positioning itself for a ‘successful recovery’ after Covid-19 cut its revenues by nearly €5 million
Investment funds buy €260m worth of Kingspan shares
Expenditure comes despite slide in the company’s share price due to Covid-19 outbreaks on construction sites and Brexit